Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 394, Issue 9

Issues

Zinc-dependent contact system activation induces vascular leakage and hypotension in rodents

Jenny Björkqvist
  • Division of Clinical Chemistry, Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden
  • Center of Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Bernd Lecher / Coen Maas
  • Division of Clinical Chemistry, Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden
  • Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Thomas Renné
  • Corresponding author
  • Division of Clinical Chemistry, Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden
  • Center of Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2013-05-01 | DOI: https://doi.org/10.1515/hsz-2013-0144

Abstract

Contact to polyanions induces autoactivation of the serine protease factor XII that triggers the kallikrei-kinin system. Recent studies indicate that polysaccharide-induced autoactivation of factor XII has a role in allergy-related vascular leakage, and angioedema. Here, we characterize in vivo effects of the synthetic polysaccharide dextran sulfate in human plasma and in rodent models. Minute amounts of high-molecular-weight dextran sulfate-initiated factor XII-autoactivation and triggered formation of the inflammatory mediator bradykinin via plasma kallikrein-mediated cleavage of high-molecular-weight kininogen. High-molecular-weight kininogen fragments, containing the HKH20 sequence in domain D5H, blocked dextran sulfate-initiated bradykinin-generation by depleting plasma Zn2+ ions. Topical application of high molecular weight dextran sulfate increased leakage in murine skin microvessels, in a bradykinin-dependent manner. Intravital laser scanning microscopy showed a greater than two-fold elevated and accelerated fluid extravasation in C1 esterase inhibitor deficient mice that lack the major inhibitor of factor XII, compared to wild-type controls. Intra-arterial infusion of dextran sulfate induced a rapid transient drop in arterial blood pressure in rats and preinjection of kinin B2 receptor antagonists or HKH20 peptide blunted dextran sulfate-triggered hypotensive reactions. The data characterize dextran sulfate as a potent in vivo activator of factor XII with implications for bradykinin-mediated vascular permeability and blood pressure control.

Keywords: angioedema; bradykinin; coagulation; inflammation; kallikrein-kinin system

References

  • Baird, T.R. and Walsh, P.N. (2002). Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation. J. Biol. Chem. 277, 28498–28503.Google Scholar

  • Bernardo, M.M., Day, D.E., Halvorson, H.R., Olson, S.T., and Shore, J.D. (1993a). Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies. J. Biol. Chem. 268, 12477–12483.Google Scholar

  • Bernardo, M.M., Day, D.E., Olson, S.T., and Shore, J.D. (1993b). Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement. J. Biol. Chem. 268, 12468–12476.Google Scholar

  • Blossom, D.B., Kallen, A.J., Patel, P.R., Elward, A., Robinson, L., Gao, G., Langer, R., Perkins, K.M., Jaeger, J.L., Kurkjian, K.M., et al. (2008). Outbreak of adverse reactions associated with contaminated heparin. N. Engl. J. Med. 359, 2674–2684.Google Scholar

  • Busse, R. and Fleming, I. (2003). Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol. Sci. 24, 24–29.Google Scholar

  • Cicardi, M., Banerji, A., Bracho, F., Malbran, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., et al. (2010). Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N. Engl. J. Med. 363, 532–541.Google Scholar

  • Cichon, S., Martin, L., Hennies, H.C., Muller, F., Van Driessche, K., Karpushova, A., Stevens, W., Colombo, R., Renne, T., Drouet, C., et al. (2006). Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am. J. Hum. Genet. 79, 1098–1104.Google Scholar

  • Citarella, F., Wuillemin, W.A., Lubbers, Y.T., and Hack, C.E. (1997). Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage. Br. J. Haematol. 99, 197–205.Google Scholar

  • Curd, J.G., Prograis, L.J. Jr., and Cochrane, C.G. (1980). Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. J. Exp. Med. 152, 742–747.Google Scholar

  • de Maat, S., van Dooremalen, S., de Groot, P.G., and Maas, C. (2013). A nanobody-based method for tracking factor XII activation in plasma. Thromb Haemost. 109. dx.doi.org/10.1160/TH12-11-0792.CrossrefGoogle Scholar

  • Greengard, J.S., Heeb, M.J., Ersdal, E., Walsh, P.N., and Griffin, J.H. (1986). Binding of coagulation factor XI to washed human platelets. Biochemistry 25, 3884–3890.Google Scholar

  • Hagedorn, I., Schmidbauer, S., Pleines, I., Kleinschnitz, C., Kronthaler, U., Stoll, G., Dickneite, G., and Nieswandt, B. (2010). Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. Circulation 121, 1510–1517.Google Scholar

  • Han, E.D., MacFarlane, R.C., Mulligan, A.N., Scafidi, J., and Davis, A.E., 3rd (2002). Increased vascular permeability in C1 inhibitor–deficient mice mediated by the bradykinin type 2 receptor. J. Clin. Invest. 109, 1057–1063.Google Scholar

  • Hasan, A.A., Cines, D.B., Herwald, H., Schmaier, A.H., and Muller-Esterl, W. (1995). Mapping the cell binding site on high molecular weight kininogen domain 5. J. Biol. Chem. 270, 19256–19261.Google Scholar

  • Herwald, H., Hasan, A.A., Godovac-Zimmermann, J., Schmaier, A.H., and Muller-Esterl, W. (1995). Identification of an endothelial cell binding site on kininogen domain D3. J. Biol. Chem. 270, 14634–14642.Google Scholar

  • Jansen, P.M., Pixley, R.A., Brouwer, M., de Jong, I.W., Chang, A.C., Hack, C.E., Taylor, F.B. Jr., and Colman, R.W. (1996). Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 87, 2337–2344.Google Scholar

  • Johne, J., Blume, C., Benz, P.M., Pozgajova, M., Ullrich, M., Schuh, K., Nieswandt, B., Walter, U., and Renne, T. (2006). Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Biol. Chem. 387, 173–178.Google Scholar

  • Kannemeier, C., Shibamiya, A., Nakazawa, F., Trusheim, H., Ruppert, C., Markart, P., Song, Y., Tzima, E., Kennerknecht, E., Niepmann, M., et al. (2007). Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc. Natl. Acad. Sci. USA 104, 6388–6393.Google Scholar

  • Kishimoto, T.K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J.C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., et al. (2008). Contaminated heparin associated with adverse clinical events and activation of the contact system. N. Engl. J. Med. 358, 2457–2467.Google Scholar

  • Kleinschnitz, C., Stoll, G., Bendszus, M., Schuh, K., Pauer, H.U., Burfeind, P., Renne, C., Gailani, D., Nieswandt, B., and Renne, T. (2006). Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J. Exp. Med. 203, 513–518.Google Scholar

  • Kluft, C., Trumpi-Kalshoven, M.M., Jie, A.F., and Veldhuyzen-Stolk, E.C. (1979). Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator. Thromb. Haemost. 41, 756–773.Google Scholar

  • Maas, C., Govers-Riemslag, J.W., Bouma, B., Schiks, B., Hazenberg, B.P., Lokhorst, H.M., Hammarstrom, P., ten Cate, H., de Groot, P.G., Bouma, B.N., et al. (2008). Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J. Clin. Invest. 118, 3208–3218.Google Scholar

  • Maas, C., Oschatz, C., and Renne, T. (2011). The plasma contact system 2.0. Semin. Thromb. Hemost. 37, 375–381.Google Scholar

  • Magneson, G.R., Puvathingal, J.M., and Ray, W.J. Jr. (1987). The concentrations of free Mg2+ and free Zn2+ in equine blood plasma. J. Biol. Chem. 262, 11140–11148.Google Scholar

  • Mahdi, F., Madar, Z.S., Figueroa, C.D., and Schmaier, A.H. (2002). Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99, 3585–3596.Google Scholar

  • Marx, G. and Eldor, A. (1985). The procoagulant effect of zinc on fibrin clot formation. Am. J. Hematol. 19, 151–159.Google Scholar

  • Meloni, F.J., Gustafson, E.J., and Schmaier, A.H. (1992). High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Blood 79, 1233–1244.Google Scholar

  • Morrissey, J.H., Choi, S.H., and Smith, S.A. (2012). Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 119, 5972–5979.Google Scholar

  • Motta, G., Rojkjaer, R., Hasan, A.A., Cines, D.B., and Schmaier, A.H. (1998). High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood 91, 516–528.Google Scholar

  • Muller, F., Mutch, N.J., Schenk, W.A., Smith, S.A., Esterl, L., Spronk, H.M., Schmidbauer, S., Gahl, W.A., Morrissey, J.H., and Renne, T. (2009). Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139, 1143–1156.Google Scholar

  • Muller, F. and Renne, T. (2011). Platelet polyphosphates: the nexus of primary and secondary hemostasis. Scand. J. Clin. Lab. Invest. 71, 82–86.Google Scholar

  • Nielsen, E.W., Johansen, H.T., Hogasen, K., Wuillemin, W., Hack, C.E., and Mollnes, T.E. (1996). Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema. Scand. J. Immunol. 44, 185–192.Google Scholar

  • Ojima, M., Hasegawa, E., Kumashiro, O., and Ogawa, T. (1988). Changes in choroidal blood flow following ligation of common carotid artery. Jpn. J. Ophthalmol. 32, 322–327.Google Scholar

  • Oschatz, C., Maas, C., Lecher, B., Jansen, T., Bjorkqvist, J., Tradler, T., Sedlmeier, R., Burfeind, P., Cichon, S., Hammerschmidt, S., et al. (2011). Mast cells increase vascular permeability by heparin–initiated bradykinin formation in vivo. Immunity 34, 258–268.Google Scholar

  • Palmer, R.M., Ferrige, A.G., and Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524–526.Google Scholar

  • Reddigari, S.R., Shibayama, Y., Brunnee, T., and Kaplan, A.P. (1993). Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268, 11982–11987.Google Scholar

  • Renne, T., Dedio, J., David, G., and Muller-Esterl, W. (2000). High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275, 33688–33696.Google Scholar

  • Renne, T., Dedio, J., Meijers, J.C., Chung, D., and Muller-Esterl, W. (1999). Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2. J. Biol. Chem. 274, 25777–25784.Google Scholar

  • Renne, T., Gailani, D., Meijers, J.C., and Muller-Esterl, W. (2002). Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein. J. Biol. Chem. 277, 4892–4899.Google Scholar

  • Renne, T. and Muller-Esterl, W. (2001). Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen. FEBS Lett. 500, 36–40.Google Scholar

  • Renne, T., Schmaier, A.H., Nickel, K.F., Blomback, M., and Maas, C. (2012). In vivo roles of factor XII. Blood 22, 4296–4303.Google Scholar

  • Renne, T., Schuh, K., and Muller-Esterl, W. (2005). Local bradykinin formation is controlled by glycosaminoglycans. J. Immunol. 175, 3377–3385.Google Scholar

  • Rojkjaer, R. and Schousboe, I. (1997). The surface–dependent autoactivation mechanism of factor XII. Eur. J. Biochem 243, 160–166.Google Scholar

  • Samuel, M., Pixley, R.A., Villanueva, M.A., Colman, R.W., and Villanueva, G.B. (1992). Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. J. Biol. Chem. 267, 19691–19697.Google Scholar

  • Schapira, M., Silver, L.D., Scott, C.F., Schmaier, A.H., Prograis, L.J. Jr., Curd, J.G., and Colman, R.W. (1983). Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N. Engl. J. Med. 308, 1050–1053.Google Scholar

  • Schmaier, A.H. (2008). The elusive physiologic role of Factor XII. J. Clin. Invest. 118, 3006–3009.Google Scholar

  • Siebeck, M., Cheronis, J.C., Fink, E., Kohl, J., Spies, B., Spannagl, M., Jochum, M., and Fritz, H. (1994). Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. J. Appl. Physiol. 77, 2675–2680.Google Scholar

  • Siegerink, B., Govers-Riemslag, J.W., Rosendaal, F.R., Ten Cate, H., and Algra, A. (2010). Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation 122, 1854–1861.Google Scholar

  • Smith, S.A., Choi, S.H., Davis-Harrison, R., Huyck, J., Boettcher, J., Reinstra, C.M., and Morrissey, J.H. (2010). Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 116, 4353–4359.Google Scholar

  • van der Meijden, P.E., Munnix, I.C., Auger, J.M., Govers-Riemslag, J.W., Cosemans, J.M., Kuijpers, M.J., Spronk, H.M., Watson, S.P., Renne, T., and Heemskerk, J.W. (2009). Dual role of collagen in factor XII-dependent thrombus formation. Blood 114, 881–890.Google Scholar

  • Vu, T.T., Fredenburgh, J.C., and Weitz, J.I. (2013). Zinc: An important cofactor in haemostasis and thrombosis. Thromb. Haemost. 109, 421–430.Google Scholar

  • Zhuo, R., Siedlecki, C.A., and Vogler, E.A. (2006). Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces. Biomaterials 27, 4325–4332.Google Scholar

  • Zuraw, B.L. (2008). Clinical practice. Hereditary angioedema. N. Engl. J. Med. 359, 1027–1036.Google Scholar

About the article

Corresponding author: Thomas Renné, MD, PhD, Division of Clinical Chemistry, Department of Molecular Medicine and Surgery, Karolinska Institutet and University Hospital, Stockholm, Sweden; and Center of Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden


Received: 2012-10-31

Accepted: 2013-04-24

Published Online: 2013-05-01

Published in Print: 2013-09-01


Citation Information: Biological Chemistry, Volume 394, Issue 9, Pages 1195–1204, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/hsz-2013-0144.

Export Citation

©2013 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Ellinor Kenne, Joel Rasmuson, Thomas Renné, Monica L. Vieira, Werner Müller-Esterl, Heiko Herwald, and Lennart Lindbom
The FASEB Journal, 2019, Volume 33, Number 2, Page 2599
[2]
Evi X. Stavrou, Chao Fang, Kara L. Bane, Andy T. Long, Clément Naudin, Erdem Kucukal, Agharnan Gandhi, Adina Brett-Morris, Michele M. Mumaw, Sudeh Izadmehr, Alona Merkulova, Cindy C. Reynolds, Omar Alhalabi, Lalitha Nayak, Wen-Mei Yu, Cheng-Kui Qu, Howard J. Meyerson, George R. Dubyak, Umut A. Gurkan, Marvin T. Nieman, Anirban Sen Gupta, Thomas Renné, and Alvin H. Schmaier
Journal of Clinical Investigation, 2018
[3]
Fabrício Simão, Tuna Ustunkaya, Allen C. Clermont, and Edward P. Feener
Blood, 2017, Volume 129, Number 16, Page 2280
[4]
S. de Maat and C. Maas
Journal of Thrombosis and Haemostasis, 2016, Volume 14, Number 8, Page 1498
[5]
E. Kenne, K. F. Nickel, A. T. Long, T. A. Fuchs, E. X. Stavrou, F. R. Stahl, and T. Renné
Journal of Internal Medicine, 2015, Volume 278, Number 6, Page 571
[6]
Izumi Ujihara, Suzuro Hitomi, Kentaro Ono, Yasuaki Kakinoki, Hirofumi Hashimoto, Yoichi Ueta, and Kiyotoshi Inenaga
Neuropharmacology, 2015, Volume 99, Page 589
[7]
Jenny Björkqvist, Steven de Maat, Urs Lewandrowski, Antonio Di Gennaro, Chris Oschatz, Kai Schönig, Markus M. Nöthen, Christian Drouet, Hal Braley, Marc W. Nolte, Albert Sickmann, Con Panousis, Coen Maas, and Thomas Renné
Journal of Clinical Investigation, 2015, Volume 125, Number 8, Page 3132
[8]
L. Labberton, E. Kenne, and T. Renné
Hämostaseologie, 2015, Volume 35, Number 4, Page 338
[9]
J. Björkqvist, K. F. Nickel, E. Stavrou, and T. Renné
Thrombosis and Haemostasis, 2014, Volume 112, Number 5, Page 868

Comments (0)

Please log in or register to comment.
Log in